Avessa 250 Inhaler

Medicine Overview

Avessa 250 Inhaler contains beclometasone dipropionate, a corticosteroid used to treat asthma and chronic obstructive pulmonary disease (COPD). It works by reducing inflammation in the airways, helping to prevent asthma attacks and manage chronic respiratory conditions. The 250 mcg dose provides effective control over symptoms such as wheezing, shortness of breath, and coughing. Avessa 250 Inhaler is ideal for regular maintenance therapy in patients with persistent asthma or COPD, offering long-term relief and improving lung function. Trusted for its safety and effectiveness, it is an essential part of managing respiratory health and improving overall quality of life.